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Abstract
Aims/hypothesis Intramyocellular lipid (IMCL) content associates with development of insulin resistance, albeit not in insulin-
sensitive endurance-trained athletes (trained). Qualitative and spatial differences in muscle lipid composition may underlie this
so-called athlete’s paradox. Here we studied triacylglycerol (TAG) composition of individual myocellular lipid droplets (LDs) in
trained individuals and individuals with type 2 diabetes mellitus.
Methods Trained (V̇O2max 71.0 ± 1.6 ml O2 [kg lean body mass (LBM)]
−1 min−1), normoglycaemic (fasting glucose 5.1 ±
0.1 mmol/l) individuals and untrained (V̇O2max 36.8 ± 1.5 ml O2 [kg LBM]
−1 min−1) individuals with type 2 diabetes (fasting
glucose 7.4 ± 0.5 mmol/l), with similar IMCL content (3.5 ± 0.7% vs 2.5 ± 0.3%, p = 0.241), but at opposite ends of the insulin
sensitivity spectrum (glucose infusion rate 93.8 ± 6.6 vs 25.7 ± 5.3μmol [kg LBM]−1 min−1 for trained individuals and those with
type 2 diabetes, respectively) were included from our database in the present study. We applied in situ label-free broadband
coherent anti-Stokes Raman scattering (CARS) microscopy to sections from skeletal muscle biopsies to measure TAG acyl chain
length and saturation of myocellular LDs. This approach uniquely permits examination of individual LDs in their native
environment, in a fibre-type-specific manner, taking into account LD size and subcellular location.
Results Despite a significant difference in insulin sensitivity, we observed remarkably similar acyl chain length and saturation in
trained and type 2 diabetic individuals (chain length: 18.12 ± 0.61 vs 18.36 ± 0.43 number of carbons; saturation: 0.37 ± 0.05 vs
0.38 ± 0.06 number of C=C bonds). Longer acyl chains or higher saturation (lower C=C number) could be detected in subpop-
ulations of LDs, i.e. large LDs (chain length: 18.11 ± 0.48 vs 18.63 ± 0.57 carbon number) and subsarcolemmal LDs (saturation:
0.34 ± 0.02 vs 0.36 ± 0.04 C=C number), which are more abundant in individuals with type 2 diabetes.
Conclusions/interpretation In contrast to reports of profound differences in the lipid composition of lipids extracted from skeletal
muscle from trained and type 2 diabetic individuals, our in situ, LD-specific approach detected only modest differences in TAG
composition in LD subpopulations, which were dependent on LD size and subcellular location. If, and to what extent, these
modest differences can impact insulin sensitivity remains to be elucidated.
Keywords Athlete’s paradox . CARS microscopy . Intramyocellular lipid storage . Lipid composition . Lipid droplet chemical
composition . Lipid droplets . Type 2 diabetes
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Excess fat can be stored ectopically as triacylglycerol (TAG)
in myocellular lipid droplets (LDs) and has been associated
with compromised insulin sensitivity [1–5]. Interestingly,
highly insulin-sensitive trained athletes also store high
amounts of myocellular fat [2, 6]. This seemingly paradoxical
observation has long been suggested to originate from elevat-
ed insulin-desensitising bioactive lipids such as diacylglycerol
and/or ceramides [7] in insulin-resistant muscle. However,
unbiased lipidomic analysis of skeletal muscle biopsies does
not consistently reveal a signature of higher levels of insulin-
desensitising bioactive lipids in the muscle of individuals with
type 2 diabetes compared with lean sedentary or physically
trained individuals (for review see [8]).
Recently, we employed a detailed morphometric analysis of
myocellular LDs in muscle biopsies obtained from individuals
encompassing the complete spectrum of insulin sensitivity [6].
We observed that athletes store most of their lipids in type I
muscle fibres in numerous, normally sized LDs in the
intramyofibrillar (IMF) area, while individuals with type 2
diabetes store most of their lipids in fewer, but larger, LDs
predominantly in the subsarcolemmal (SS) area of type II
muscle fibres. Lipid storage in the SS region correlated nega-
tively with insulin sensitivity. Upon an insulin-sensitising exer-
cise training programme, the LD phenotype (i.e. morphology
and location) in type 2 diabetic individuals shifted partly towards
an athlete-like phenotype. Jointly, these data suggest that LD
location and size are both correlated with insulin sensitivity.
Typically, information on LDs with respect to subcellular
distribution (fibre type and SS vs IMF) and LD size is lost
upon lipid extraction in conventional lipidomic analysis. Our
observation that size and subcellular distribution of LDs are
different between type 2 diabetic individuals and athletes
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stresses the need for an approach that takes size and location
into account while analysing myocellular LD composition.
Recently, we employed the quantitative non-linear vibrational
microscopy method broadband coherent anti-Stokes Raman
scattering (CARS/BCARS) microscopy to measure character-
istics of lipids of single LDs [9]. In tandem with optical
microscopy, label-free BCARS microscopy permits in situ
quantitative analysis of the chemical characteristics specific
to lipid fibre type in their native environment and with a high
spatial resolution (~300 nm). Specifically, this approach
permits quantitative analysis of average TAG acyl chain
length and level of saturation [10]. Both acyl chain length
and saturation are recognised determinants of the insulin-
desensitising potency of fatty acids [11, 12].
Here we employed an in situ, label-free BCARSmicroscopy
approach on muscle biopsy samples derived from participants
spanning the physiological range of insulin sensitivity. We
uniquely aimed to study whether the observation that LD size
and location correlate with insulin sensitivity can be explained
by a differential TAG composition of LDs in muscle biopsies
from athletes vs type 2 diabetic individuals. We hypothesised
that acyl chain length is longer and that the degree of saturation
is higher in myocellular LDs of type 2 diabetic individuals as
opposed to athletes. More specifically, we hypothesised that the
acyl chain length and the degree of saturation are higher in large
LDs as well as in LDs present in the SS area.
Methods
Participants Eight endurance-trained athletes (trained; V̇O2max
>55 ml O2 [kg lean body mass (LBM)]
−1 min−1) and eight
type 2 diabetic individuals were selected from previous stud-
ies (see Vosselman et al [13] and Brouwers et al [14]). Trained
and type 2 diabetic individuals were included upon matching
for total intramyocellular lipid (IMCL) content as determined
by the fraction of LD area over the muscle fibre area,
measured previously in this cohort [6]. In short, LDs were
staining with Bodipy 493/503 and imaged with widefield
microscopy. The original studies were executed in agreement
with the Declaration of Helsinki and approved by the Medical
Ethical Committee ofMaastricht University. Participants gave
written informed consent before participating in the original
study, registered at clinicaltrials.gov as NCT01317576.
Muscle biopsy and metabolic measurementsMuscle biopsies
and metabolic measurements have been described in more
detail previously [13, 14]. After an overnight fast a biopsy
was taken from the vastus lateralis muscle, frozen in melting
isopentane and stored at −80°C. Directly after the muscle
biopsy a hyperinsulinaemic–euglycaemic clamp (40 mU insu-
lin, 5.5 mmol/l glucose) was performed and glucose infusion
rate (GIR) was determined as a measure for whole body
insulin sensitivity. To determine V̇O2max, a graded maximal
cycling test with indirect calorimetry (Omnical, Maastricht,
the Netherlands) was executed until exhaustion. GIR and
V̇O2max are expressed per kg LBM to correct for differences
in fat mass. Body composition was measured with a dual-
energy x-ray absorptiometry (DXA) scan.
BCARS microscopy LD composition was measured in a fibre-
type-specific fashion. Four μm sections were stained against
laminin (L9393, Sigma, St Louis, USA) and myosin heavy
chain type I (A4.840, Developmental Studies Hybridoma
Bank, Iowa City, IA, USA) [6]. Scout images of the sections
were acquired on an Olympus IX80 inverted microscope for
muscle fibre typing prior to CARS imaging [9]. In short, a
dual-output laser source (Leukos-CARS, Leukos) provided a
1064 nm beam at 32 kHz repetition rate. That beam was split
into the pump/probe (1064 nm) and Stokes beams (1100–
1800 nm via a photonic crystal fibre and long-pass filter).
Both lasers were routed on an optical table to excite the
sample mounted on a stepper-motor stage (Microstage, Mad
City Labs, Switzerland) with a nested piezo stage (Nano-PDQ
375 HS, Mad City Labs). Type I and type II fibre area was
scanned in nine tiles of 25× 25 μm. Three fields of view per
participant were imaged with 250 nm pixel size. CARS spec-
tra were acquired between 600 and 3400 cm−1 and detected by
a deep-depletion CCD (Newton DU920P-BR-DD, Andor,
Oxford Instruments, Abingdon, United Kingdom) using
custom written software (Labview, National Instruments).
Extraction of characteristic LD spectra CARS spectra were
analysed using IgorPro 6.37 (Wavemetrics; https://www.
wavemetrics.com/) and converted into Raman-like (RL) spec-
tra [15, 16]. CH2-intensity based images were constructed by
integrating the RL signal from 2840 to 2855 cm−1. In these
CH2 images, regions of interest (ROIs) were created for
further analysis of the LDs using an iterative threshold. The
RL spectra in these pixels were reconstructed using five
components as described by Paul et al [10]. These compo-
nents were derived from RL spectra of a set of known TAG
standards and their mixture (TAG backbone, TAG acyl chain
length, TAG number of double bonds), a BSA RL-spectrum
(generic protein), and TAGs diluted in organic solvents (TAG
dilution). These data were combined to retrieve the acyl chain
length and number of double bonds per acyl chain (C=C
number) of unknown TAGs in the LDs.
Calculating average acyl chain lengths and C=C number in
LDs Images of CH2 intensity, acyl chain length and C=C
number map were analysed in ImageJ 1.51 j8 (NIH,
Bethesda, USA). ROIs for fibre types (as identified by fluo-
rescence labelling) were drawn from the CH2 images and
applied to the acyl chain length and C=C number maps to
Diabetologia
obtain fibre-type-specific data. Acyl chain length and C=C
number dependence on LD size was determined specifically
for the type 2 diabetic individuals, as we previously observed
that these individuals display large LDs [6]; LDs <4 pixels in
area were excluded from analysis. Thus, a histogram of all LD
sizes for each individual was generated with the lower 50%
being defined as ‘small’ LDs (on average <1.17 μm2) and the
upper 10% as ‘large’ (on average >3.45 μm2). This permitted
the computation of the average acyl chain length and C=C
number for small and large LDs. Similarly, acyl chain length
and C=C number were assessed for LDs in the SS vs the IMF
region [6]. Thus, average acyl chain length and C=C number
were calculated as the weighted average of the values of type I
and II fibres [6]. Group means per fibre type were computed
by averaging all spectra per individual and subsequently
computing the mean of this average over all athletes or type
2 diabetic individuals in the respective groups.
StatisticsData are presented as mean ± SD unless stated other-
wise. Statistical analyses were performed using SPSS version
21.0 (SPSS, Chicago, IL, USA). Participant characteristics as
well as acyl chain length and C=C number were compared
between groups using an independent samples t test. SS and
IMF LDs as well as large and small LDs were compared for
acyl chain length andC=C number using a paired samples t test.
A p value <0.05 was considered to be statistically significant.
Results
Participant characteristics Participant characteristics have
previously been reported [13, 14] and are now shown in
Table 1. Type 2 diabetic individuals were significantly older
and had a higher body mass, percentage fat mass and BMI than
trained individuals (all p < 0.05). As expected, trained individ-
uals had higher insulin sensitivity (expressed by GIR) and
V̇O2max and lower fasting plasma glucose levels than type 2
diabetes individuals (all p < 0.05). By design, trained and type 2
diabetic individuals had similar IMCL content (3.5 ± 0.7% vs
2.5 ± 0.3%, p = 0.241).
Overall acyl chain length and saturation is not different
between trained and type 2 diabetic individuals We first
aimed to identify, in a fibre-type-dependent fashion, whether
TAG acyl chain length and saturation of myocellular LDs
differed between trained and type 2 diabetic individuals.
LDs could be readily identified based on CH2 intensity images
(Fig. 1a) owing to a high abundance of acyl chains in LDs.
Over the entire spectral range, the average RL spectra of
trained and type 2 diabetic individuals were strikingly similar.
This similarity was observed in type I and type II fibres (Fig.
1b, c), indicating that the chemical composition of the LDs in
trained and type 2 diabetic individuals was similar. More
specifically, this was observed for the CH region (2800–
3100 cm−1), as well as for the ‘fingerprint region’ (700–
1750 cm−1), which includes characteristic resonances of
complex macromolecules, including lipids and proteins.
From the average spectra for each group, average acyl
chain length and average number of double bonds per acyl
chain (C=C number, representing the level of unsaturation)
of TAGs was determined. This way of computing can
result in fractional data for acyl chain length and number
of double bonds; e.g. if a TAG molecule is composed of
two C16:0 acyl chains and one C18:1, CARS will give
Table 1 Participant characteristics
Variable Trained T2DM
Age (years) 26.0 ± 1.8 60.6 ± 2.0*
Body weight (kg) 72.4 ± 2.6 95.9 ± 2.8*
% Fat mass 13.4 ± 0.5 28.3 ± 0.9*
BMI (kg/m2) 21.0 ± 0.6 29.6 ± 0.8*
Fasting glucose (mmol/l) 5.1 ± 0.1 7.4 ± 0.5*
GIR (μmol [kg LBM]−1 min−1) 93.8 ± 6.6 25.7 ± 5.3*
V̇O2max (ml O2 [kg LBM]
−1 min−1) 71.0 ± 1.6 36.8 ± 1.5*
IMCL (%) 3.49 ± 0.69 2.48 ± 0.29
Fasting insulin (pmol/l) – 107.7 ± 25.7
HOMA-IR (%) – 5.5 ± 1.0
Glucose-lowering medication (number of individuals) Metformin (n = 7)
DPP-4 inhibitor (n = 2)
Sulfonylurea (n = 2)
Data are mean ± SEM, n = 8 for each group, except where shown otherwise
*p < 0.05 vs Trained
T2DM, type 2 diabetes mellitus
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C16.67:0.33 as average chain length and number of double
bonds. In contrast to what was anticipated, no differences
were observed between acyl chain length in trained and type
2 diabetic individuals (18.12 ± 0.61 vs 18.36 ± 0.43 number of
carbons for trained and type 2 diabetic individuals, respective-
ly; p = 0.38, Fig. 1d). When examined in a fibre-type-specific
fashion, acyl chain length in type I fibres of trained individuals
was similar to acyl chain length measured in type 2 diabetic
individuals (17.93 ± 0.68 vs 18.34 ± 0.51 carbon number for
trained and type 2 diabetic individuals, respectively; p = 0.20,
Fig. 1d). A similar observation was made for acyl chain length
in type II fibres (18.30 ± 0.70 vs 18.38 ± 0.42 carbon number


































































































Fig. 1 TAG chain length and
saturation of LDs does not differ
between trained and type 2
diabetic individuals. (a)
Representative images of the
integrated CH2 intensity (2840–
2855 cm−1), revealing the LDs in
type I and type II fibres of trained
and type 2 diabetic (T2DM)
individuals, with fibre borders
indicated in white; scale bars,
20 μm. (b, c) Average CARS
spectra of LDs of trained and type
2 diabetic individuals, showing
fingerprint intensity and intensity
in the CH region (2800–
3100 cm−1), in type I (b) and type
II (c) fibres (mean ± SD); the
enlarged, framed peaks in (c)
have been broadened to show
differences and similarities more
clearly. (d) Number of carbons
per acyl chain and (e) number of
double bonds per acyl chain (C=C
number) within LDs for all fibres,
type I fibres and type II fibres of
trained and type 2 diabetic
individuals (mean ± SD). n = 8
for each group
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As a reflection of the level of saturation of the acyl chains,
the number of double bonds per acyl chain was measured. We
observed that the number of double bonds was similar in
trained vs type 2 diabetic individuals (0.37 ± 0.05 vs 0.38 ±
0.06 C=C number for trained and type 2 diabetic individuals,
respectively; p = 0.71, Fig. 1e). This lack of difference in satu-
ration between trained and type 2 diabetic individuals was
observed in type I (0.35 ± 0.04 vs 0.40 ± 0.10 C=C number
for trained and type 2 diabetic individuals, respectively; p =
0.27, Fig. 1e) as well as in type II fibres (0.39 ± 0.05 vs 0.36 ±
0.04 C=C number for trained and type 2 diabetic individuals,
respectively; p = 0.31, Fig. 1e).
Region specific differences in acyl chain length and saturation
of myocellular LDs SS lipid storage is considered detrimental
for insulin sensitivity [6, 17–19]. In support of this, we previ-
ously observed a negative correlation between insulin sensi-
tivity and SS LD size and number over a wide range of insulin
sensitivity [6]. The current approach allows for creating
spatial maps of lipid chemistry: acyl chain length and C=C
number of SS and IMF LDs (Fig. 2a) and relate this to the
insulin sensitivity spectrum encompassed by trained and type
2 diabetic individuals. When examining the combined muscle
fibre types and pooled groups, acyl chain length in SS were
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Fig. 2 Saturation is higher in SS LDs. (a) CH2 intensity image (left) and
spatial maps of chain length (middle) and C=C number (right) of a repre-
sentative image of a trained participant, with magnified images below
(indicated in the original image by a red box; note that the resolution of
the zoomed images is the maximum possible, given the system used).
Colour scales represent number of carbons per acyl chain (middle) or
C=C number (right). In these images the SS region was identified by
using an individual predetermined SS diameter (as illustrated by the blue
area in the CH2 intensity image). Fibre borders are indicated in white and
black; scale bars, 20μm. (b, c) Acyl chain length (b) and C=C number (c)
of SS and IMF LDs in all fibres, type I fibres and type II fibres of all
participants; n = 16 (mean ± SD). (d) C=C number in LDs in type II fibres
separated for trained and type 2 diabetic (T2DM) individuals; n = 8 for
each group (mean ± SD). *p < 0.05 vs SS in the same group
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18.22 ± 0.64 carbon number for respectively SS and IMF, p =
0.077, Fig. 2b). This modest effect on acyl chain length was
specific for type II fibres (18.07 ± 0.86 vs 18.37 ± 0.55 carbon
number for SS and IMF, respectively; p = 0.06, Fig. 2b) and
not for type I fibres (17.99 ± 1.00 vs 18.12 ± 0.81 carbon
number for SS and IMF, respectively; p = 0.31, Fig. 2b).
Interestingly, the number of double bonds was significantly,
albeit modestly, lower in the SS region compared with the
IMF region when the groups were pooled (0.34 ± 0.02 vs
0.36 ± 0.04 C=C number for SS and IMF, respectively;
p < 0.05, Fig. 2c). This lower C=C number was observed in
the mixed fibre population, but was driven by differences
specifically in type II fibres (0.35 ± 0.04 vs 0.38 ± 0.05 C=C
number for SS and IMF, respectively; p < 0.05, Fig. 2c).
Next, we examined whether the spatial differences in C=C
number that were detected in type II fibres over the entire
range of insulin sensitivity also was detectable if trained and
type 2 diabetic individuals were examined separately.
Interestingly, we observed a significantly lower C=C number
in SS LDs compared with IMF LDs in type II fibres in type 2
diabetic individuals (0.35 ± 0.04 vs 0.38 ± 0.05 C=C number
for SS and IMF, respectively; p < 0.01, Fig. 2d), but not in
trained individuals (0.36 ± 0.04 vs 0.38 ± 0.05 C=C number
for SS and IMF, respectively; p = 0.31, Fig. 2c). Thus, over
the entire range of insulin sensitivity, acyl chains in the IMF
region had more double bonds than in the SS region, an obser-
vation made in type II, but not in type I fibres. Upon separat-
ing the trained and the type 2 diabetic samples, the difference
in double bonds between the SS and IMF LDs was only
detected in the type 2 diabetic individuals.
Higher acyl chain length in large LDsWe previously reported
in the same cohort that LDs are larger in type II fibres of type 2
diabetic individuals than in trained individuals and observed a
negative correlation between LD size and insulin sensitivity
[6]. Thus, we specifically aimed to investigate whether large
LDs in type 2 diabetic individuals differed in acyl chain length
and saturation compared with the more frequently present
smaller sized LDs. The spatial maps of acyl chain length and
C=C number allowed us to directly relate LD size to acyl
chain length and C=C number (Fig. 3a). Large LDs were
defined as the 10% largest LDs and small LDs as the 50%
a
Chain length  C=C number
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Fig. 3 Higher chain length in large LDs. (a) CH2 intensity image (left)
and spatial maps of chain length (middle) and C=C number (right) of a
representative image of a type 2 diabetic (T2DM) participant. Colour
scales represent number of carbons per acyl chain (middle) or C=C
number (right). Small LDs indicated by black arrows, large LDs indicated
by grey arrows. Fibre borders are indicated in white and black; scale bars,
20 μm. (b, c) Acyl chain length (b) and C=C number (c) of small and
large LDs in all fibres, type I fibres and type II fibres (mean ± SD)
*p < 0.05 vs small LDs in the same group; n = 8 for large and small LDs
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smallest LDs present in the type 2 diabetic individuals. We
performed analysis of acyl chain length and C=C number in
relation to LD size only in type 2 diabetic individuals, because
in the trained individuals we found hardly any LDs that are as
large as the largest 10% LDs in the type 2 diabetic individuals.
Interestingly, we observed that acyl chains of large LDs were
significantly longer compared with small LDs, upon examin-
ing both type I and type II muscle fibres (18.11 ± 0.48 vs
18.63 ± 0.57 for small and large LDs, respectively; p < 0.05,
Fig. 3b). This difference is visualised in the spatial maps,
where large LDs often displayed longer acyl chains than small
LDs (Fig. 3a, indicated by the grey arrows vs black arrows,
respectively). We observed that the difference in LD compo-
sition between small and large LDs predominantly originated
from LDs in type I fibres (18.23 ± 0.69 vs 18.77 ± 0.44 carbon
number for small and large LDs, respectively; p < 0.05, Fig.
3b). For type II fibres statistical significance was not reached
(18.01 ± 0.48 vs. 18.46 ± 0.77 carbon number for small and
large LDs, respectively; p = 0.25, Fig. 3b). The number of
double bonds was similar between large and small LDs (all
fibres: 0.37 ± 0.05 vs 0.37 ± 0.04 C=C number for small and
large, respectively; p = 0.70, Fig. 3c). Thus, the large LDs
present in type 2 diabetic individuals have a longer acyl chain
length compared with smaller, normally sized LDs in the same
patient population.
Discussion
This study is the first to compare the composition of individual
myocellular LDs between two populations representing the
two extremes of the insulin sensitivity spectrum in a spatial
and fibre-type-specific fashion. Given the notable differences
in insulin sensitivity between trained and type 2 diabetic indi-
viduals, and the putative insulin-desensitising effects of
intramyocellular lipids, we were anticipating that we would
detect profound differences in composition of myocellular
LDs in skeletal muscle biopsies of trained vs type 2 diabetic
individuals. The composition of LDs with respect to chemical
bonds that are detectable with BCARS, however, was remark-
ably similar for trained and type 2 diabetic individuals.
Specifically, length and saturation of the acyl chains within
LDs were not different between trained and type 2 diabetic
individuals. We previously observed, however, that it is not
overall LD content, but specific subpopulations of LDs (i.e.
large LDs and SS LDs), that associate with insulin resistance
[6]. Thus, we took advantage of the unique ability of in situ
chemical imaging with the BCARS microscopy approach to
analyse the composition of individual LDs in a muscle-fibre-
type specific fashion and in relation to LD size and spatial
distribution. Spatial analysis of acyl chain length and C=C
number revealed the novel insight that acyl chains found in
LDs in the SS area were shorter, albeit not statistically
significant, and more saturated than acyl chains in IMF LDs.
Furthermore, acyl chains in large LDs (typically correlated
with lower insulin sensitivity) in type 2 diabetic individuals
typically are longer than acyl chains in smaller, normally sized
LDs. The differences in composition are more distinct in type
II rather than in type I muscle fibres, in SS rather than in IMF
LDs, and in large rather than small LDs. All these variables
have previously been reported to relate to low rather than high
insulin sensitivity [6, 17, 18]. Nevertheless, it should be noted
that the differences in acyl chain length and saturation appear
only modest (albeit significant) and only in a subpopulation of
LDs and that it remains unclear if these differences indeed
contribute to the development of insulin resistance.
Previous studies have indicated that acyl chain length and
saturation of TAGs in the plasma are associated with risk for
diabetes [20] as well as improvements in insulin sensitivity
after diet-induced weight loss [21]. Specifically in the muscle,
it has been reported that saturated TAGs negatively correlate
with insulin sensitivity when measured after lipid extraction
from muscle [22]. Furthermore, an increased saturated acyl
content of TAGs was reported in skeletal muscle of
normoglycaemic obese participants compared with
normoglycaemic lean participants [22]. The present study
reveals that the increased saturation that was previously
reported most likely does not originate from acyl chains found
in LDs as we did not detect differences in acyl chain length or
saturation in the overall LD pool between trained and type 2
diabetic individuals.
Impaired insulin signalling in insulin-resistant muscle has
long been attributed to (elevated) presence of bioactive lipid
derivatives, commonly thought to originate from excess lipid
storage in muscle [23]. Bioactive lipids of a wide variety of
species are commonly measured by lipidomics. Lipidomic
approaches require lipid extraction of the sample followed
by mass spectrometry to quantify the individual lipid species.
However, upon extracting lipids from their native environ-
ment, all spatial information is lost. LD location appears to
be a determinant (or at least reflective) of insulin sensitivity.
Specifically, lipids in the SS region have been proposed to
affect insulin sensitivity as lipids can readily interfere with
insulin signalling at the cell membrane, owing to their close
proximity. We and others observed a negative correlation
between insulin sensitivity and SS LDs [6, 17, 18]. Thus, we
aimed to investigate whether this correlation could result from
a differential composition between SS and IMF LDs. We
observed that SS LDs were modestly but significantly more
saturated compared with acyl chains in IMF LDs in type II
fibres. Although this difference was most pronounced in the
type 2 diabetic individuals, we did not observe differences in
the composition of SS LDs nor IMF LDs between trained and
type 2 diabetic individuals. However, we previously reported
that lipid storage in the SS region of type II muscle fibres is
almost fourfold higher in type 2 diabetic individuals compared
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with trained athletes [6]. Thus, this higher SS lipid storage in
the muscle of type 2 diabetic individuals can contribute to an
elevated storage of saturated acyl chains in the SS region of
type 2 diabetic compared with trained individuals. Lipids in
the SS regions have previously been associated with compro-
mised insulin sensitivity. It has, for example, been shown that
the fatty acid composition of phospholipids in the sarcolemma
may affect insulin sensitivity; specifically the degree of
unsaturation correlated positively with insulin sensitivity
[24]. Likewise, specifically ceramides located in the sarcolem-
ma [25] and membrane-associated saturated diacylglycerols
associated negatively with insulin sensitivity [19]. The storage
of more saturated acyl chains in SS LDs in the vicinity of the
sarcolemma may contribute to alterations in lipid composition
of the sarcolemma and hence impede insulin signalling.
We previously observed that type 2 diabetic individuals are
characterised by large LDs in type II fibres compared with
trained individuals [6]. In line with this, multiple studies have
reported that LD size negatively correlates with insulin resis-
tance [6, 17, 26]. Thus, we aimed to specifically investigate
the composition of these large LDs observed in type 2 diabetes
individuals. We compared acyl chain length and saturation of
large LDs to smaller, normally sized LDs and observed that in
large LDs acyl chains are longer than in small LDs. Thus, the
higher prevalence of large LDs in type 2 diabetic individuals
as opposed to trained athletes indicates an increased presence
of longer acyl chains. This observation is in line with previous
cell and animal studies showing that fatty acids with a longer
chain length contribute to insulin resistance, as opposed to
fatty acids with a shorter acyl chains [12, 27, 28].
Our initial hypothesis, based upon targeted or unbiased
lipidomic studies of lipids extracted from muscle cells, was
that we would detect more deleterious lipid moieties in
myocellular LDs in muscle biopsies from individuals with
type 2 diabetes than in trained individuals. Our data do not
support this hypothesis and hence are not in line with (most)
data on lipid composition in lipids extracted frommuscle. It is
important to note that we previously have employed the same
CARS-based technology to examine lipid compositional
differences upon overexpression of the LD coat protein
perilipin 5 (PLIN5). Overexpression of PLIN5 in rat skeletal
muscle and cultured myotubes resulted in augmented storage
of fat in large LDs and significant alterations in composition
of the lipids in these LDs [9]. At present, BCARS and other
vibrational microscopy techniques are the only label-free
methods that do not require any kind of lipid extraction or
pre-treatment of samples that may affect lipid composition.
Hence, this approach is attractive for its ability to obtain sensi-
tive information on composition of lipids within individual
LDs in their native environment. Thus, the apparent discrep-
ancy of our data with lipidomic analyses of lipids extracted
from muscle may well originate from differences in method-
ology. Lipids extracted from muscle not only reflect the
composition of the lipids within LDs, but also contain
membrane lipids and membrane-associated lipids, which by
virtue of their cellular location, are more prone to impede
insulin signalling than lipids present within LDs. To examine
if indeed these methodological differences underlie the appar-
ent discrepancy between the LD-specific data in the present
and other studies, future studies should combine in situ anal-
ysis with mass spectrometry, such as secondary ion mass
spectrometry (SIMS) or matrix-assisted laser desorption/
ionisation mass spectrometry imaging (MALDI-MSI); this
will also provide more information on the lipid species
involved. The recent introduction of nano-SIMS may even
bring the spatial resolution down to a level that permits exam-
ination of individual LDs in situ [29].
The lack of a normoglycaemic, young, lean and untrained
group for comparison with the athletes, and a normoglycaemic
group that was BMI- and age-matched to the individuals with
type 2 diabetes, could be considered a limitation of the present
study. Instead of matching to these phenotypic differences, we
matched for total IMCL content, which, irrespective of age or
leanness, is considered to be the culprit for myocellular insulin
resistance. Thus, the effect of IMCL on insulin sensitivity can be
compared directly in two groups representing both extremes of
the insulin sensitivity spectrum.
In conclusion, in situ label-free analysis of acyl chain
length and saturation of individual myocellular LDs by
CARS microscopy reveal a remarkable similarity in composi-
tion of LDs of insulin-sensitive trained individuals and type 2
diabetic individuals. This method of analysis allowed us to
directly relate lipid composition to subcellular location and
size of LDs. Higher acyl chain length or saturation could be
detected in subpopulations of LDs, i.e. large LDs and SS LDs,
respectively, which are more abundant in type 2 diabetic indi-
viduals and have been linked to insulin resistance. However, if
and to what extent these modest differences in acyl chain
length and saturation (which were only detected in LD
subpopulations), can indeed impact insulin sensitivity remains
to be elucidated.
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